PARTIAL SPLENIC EMBOLIZATION-MINIMALLY INVASIVE ALTERNATIVE TO SURGICAL SPLENECTOMY IN THROMBOCYTOPENIC HYPERSPLENISM. A SINGLE CENTER EXPERIENCE
DOI:
https://doi.org/10.22551/1psdrc07Abstract
Partial splenic embolization (PSE) is a minimally invasive procedure that replaced radical surgical intervention of splenectomy for the treatment of severe cytopenia, mainly life-threatening thrombocytopenia secondary to hypersplenism in advanced liver disease. Materials and methods: This is an observational, retrospective and analytical study of 15 patients undergoing PSE from “St. John” Emergency Hospital Bucharest, admitted to Gastroenterology Clinic for several complications of liver cirrhosis, during May 2013-July 2019, while the patients’ survival rate was followed up until November 2024. Results: Our results confirm once again that PSE is a reliable nonsurgical technique used to improve the consequences of hypersplenism associated with portal hypertension in chronic liver disease, especially in liver cirrhosis. Generally, the postembolization course was uneventful; non-severe complications developed and were properly managed by conservative treatment. Conclusions: A significant improvement of platelet number was obtained in all patients, allowing better outcome for each case, especially if a surgical intervention is scheduled.
References
1. Zhu K, Meng X, Qian J, et al. Partial splenic embolization for hypersplenism in cirrhosis: A long-term outcome in 62 patients. Digestive and Liver Disease 2009; 41(6): 411-416.
2. Premkumar M, Anil C. Anand. Overview of Complications in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022; 12(4): 1150-1174.
3. Lv Y, et al Hypersplenism History and current status. Experimental and therapeutic Medicine 2016; 12: 2377-2382.
4. Morawitz P, Denecked G. Erkrankungen der Milz. In: Handbuch der inneren Medizin. Volume 4. 2nd edition. von Bergmann G and Staehelin R (eds.) Berlin: Springer, 1926, 217-236.
5. Boyer TD, Habib S. Big spleens and hypersplenism: fix it or forget it? Liver Int 2015; 35: 1492-1498.
6. Morsy MAM, Abdelsamad AM, et al. Partial Splenic Artery Embolization in Chronic Liver Disease. The Egyptian Journal of Hospital Medicine 2018; 71(2); 2429-2433.
7. Sangro B, et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology 1993; 18(2): 309-314.
8. Leideck P, et al. The role and evolution of partial splenic embolization over three decades: A multi-centric retrospective single cohort study of 90 patients from French nationwide experience. Clin Res Hepatol Gastroenterol 2024; 48(6): 102355.
9. Hadduck TA, McWilliams JP. Partial splenic artery embolization in cirrhotic patients. World J Radiol 2014; 6(5): 160-168.
10. Ueda J, et al. Evaluation of splenic infarction ratio and platelet increase ratio after partial splenic artery embolization. Journal of International Medical Research 2023; 51(8): 1-8.
11. Tan Y, Wang J, Sun L, et al. Repeated partial splenic artery embolization for hypersplenism improves platelet count. Open Med (Wars) 2022; 17: 808-815.
12. Hayashi H, Beppu T, Masuda T, et al Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol 2007; 22: 1638-1642.
13. Talwar A, Gabr A, Riaz A, et al. Adverse Events Related to Partial Splenic Embolization for the Treatment of Hypersplenism: A Systematic Review. J Vasc Interv Radiol 2020; 31(7): 1118-1131.
14. Gowda NK, D’Souza D, Golzarian J. Partial splenic artery embolization. Endovasc Today 2012; 11: 74-76.
15. Maddison FE. Embolic therapy of hypersplenism. Invest Radiol 1973; 8: 280-281.
16. Spigos DG, Jonasson O, Mozes M, Capek V. Partial splenic embolization in the treatment of hyper-splenism. AJR Am J Roentgenol. 1979; 132(5): 777-782.
17. Ishikawa T, Sasaki R, Nishimura T, et al. Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism. J Gastroenterol 2021; 56: 382-394.
18. Hayashi H, Beppu T, Okabe K, et al. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg 2008; 95: 744-750.
19. Hayashi H, et al. Management of thrombocytopenia due to liver cirrhosis. World J Gastroenterol 2014; 20(10): 2595-2605.
20. Ou MC, Chuang MT, Lin XZ, et al. A novel method for the angiographic estimation of the percentage of spleen volume embolized during partial splenic embolization. European Journal of Radiology 2013; 82(8): 1260-1265.
21. Zhang L, et al. Severe Complications After Splenic Artery Embolization for Portal Hyper-tension Due to Hepatic Cirrhosis. Risk Management and Healthcare Policy 2020; 13: 135-140.
22. Ahuja C, Farsad K, Chadha M. An Overview of Splenic Embolization. AJR Am J Roentgenol 2015; 205(4): 720-725.
23. N’Kontchou G, Seror O, Bourcier V, et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol 2005; 17: 179-184.
24. Koconis KG, Singh H, Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: a review of the English language literature. J Vasc Interv Radiol 2007; 18: 463-481.
25. Wang YB, Zhang JY, Zhang F, Zhao Y, Gong JP. Partial splenic artery embolization to treat hyper-splenism secondary to hepatic cirrhosis: a meta-analysis. Am Surg 2017; 83(3): 274-283.

Additional Files
Published
Issue
Section
License
Copyright (c) 2025 The Medical-Surgical Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
COPYRIGHT
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
_____________________________________________________________________________________
_____________________________________________________________________________________
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
- ______________________________/_________________________
- ______________________________/_________________________
- ______________________________/_________________________
N.B. All the authors must sign this form